Updated hourlyHourly refreshMon, Sep 21, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · Healthcare
MAINZ, Germany, and ROCKVILLE, USA, September 14, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today announced the first median overall survival (“OS”) data from the non-pivotal stage 1 of the global randomized PRESERVE-003 Phase 3 clinical trial ( NCT05671510 ) of gotistobart (also known as BNT316 or ONC-392), in patients with squamous non-small lung cancer (“NSCLC”) whose disease progressed on prior immunotherapy and chemotherapy. Gotistobart is an investigational CTLA-4-targeting immunotherapy designed to selectively deplete regulatory T cells (“Tregs”) within the tumor microenvironment and restore anti-tumor immune activity.
Sep 14 · 08:00·GlobeNewswire
Healthcare
Novo Nordisk will mark the beginning of its next chapter by unveiling a rebrand centred on ‘Lasting Health Starts Now’, and the single ‘Novo’ name ...
Sep 14 · 07:05·GlobeNewswire
Healthcare
An upcoming educational feature explores the critical intersection of community-driven workforce programs and modern rural hospital sustainability. LOS ANGELES, Sept. 14, 2026 /PRNewswire/ -- The educational series "All Access hosted by Andy Garcia" will document a compelling solution to...
Sep 14 · 07:00·PR Newswire
Healthcare
CHENGDU, China, Sept. 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", 6990.HK) announced that results from the phase III registrational study of its novel human epidermal growth factor receptor 2 (HER2)-targeted antibody–drug...
Sep 14 · 06:18·PR Newswire
Finance · SaaS
(PR-inside.com) Three-year enterprise agreement with a total three year contract value of approximately US$78,000 (approximately EUR 67,000) in total, covering an enterprise-wide deployment and full Epic and MyChart integration. LONDON, GB / ACCESS Newswire / September 14, 2026 / Physitrack PLC (STO:PTRK), a global provider of digital health and wellbeing technology, today announces that it has been selected as the digital rehabilitation platform for a US metropolitan safety net healthcare system, following a competitive selection process. The agreement covers a three-year relationship with a break option after the second year. It represents annual recurring revenue of approximately US$26,500 (approximately EUR 22,800) in the ..
Sep 14 · 06:00·PR-Inside
Healthcare
- Head of 295-year-old Japanese Pharmaceutical Pioneer to Present Asia's Longevity Growth Strategies and Bioscientific Research Initiatives at Prestigious Conference - TOKYO and GSTAAD, Switzerland, Sept. 14, 2026 /PRNewswire/ -- Abe Yoando Pharma Co., Ltd., a nearly 300-year-old...
Sep 14 · 06:00·PR Newswire
Healthcare
Elder Care has released a mobile application that allows family caregivers to photograph and store medical documents from doctors and hospitals, providing centralized access for authorized family members.
Sep 14 · 05:40·PressReleaseNews
Healthcare
Allschwil, Switzerland, September 14, 2026
Sep 14 · 05:15·GlobeNewswire
Healthcare
SHANGHAI and HONG KONG, Sept. 14, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for...
Sep 14 · 04:26·PR Newswire
Healthcare
RYBREVANT plus chemotherapy demonstrates durable benefit with a differentiated approach that dual-targets EGFR and MET Results mark significant progress for a patient population with poor outcomes and a historical five-year survival rate of just 8% SEOUL, South Korea, Sept. 13, 2026...
Sep 14 · 01:45·PR Newswire
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 13, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sep 13 · 22:02·PR-Inside
Finance · Healthcare
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 13, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ:GUTS) and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-07167, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Fractyl securities between January 13, 2025 and January 29, 2026, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations ..
Sep 13 · 15:01·PR-Inside